Communication for Peaceful Social Change and Global Citizenry

The adoption of the 17 Sustainable Development Goals (SDGs) by the United Nations (UN) in 2015 represents a universal call to action involving multiple international actors for the purpose of eradicating poverty, improving living conditions and promoting peace. This entry provides a theoretical overview of the contributions of scholars and practitioners who highlight the importance of a transformative, educational and emancipatory communication by different social actors to establish the main lines of action for the 2030 Agenda for Sustainable Development. This communicative model involves the coordination of actors and strategies, both short- and long-term, cross-cutting actions and discourses to build social, cultural and political settings based on the criteria of peace, equality, social justice and human rights. Specifically, this entails a contribution to the objectives set out in SDG 16, “Peace, Justice and Strong Institutions”, given that the proposed theoretical framework is grounded in Communication for Peace and Communication for Social Change, and includes a systematization of different strategies and experiences from a variety of social issuers, mainly institutions, non-governmental organizations (NGOs) or social movements, aimed at promoting peaceful and inclusive societies. Specifically, communication for peaceful social change and global citizenry contributes to the achievement of specific SDG 16 objectives, particularly 16.1: Significantly reduce all forms of violence... [...

Fishing for litter, accidental catch in bottom trawl nets along the Catalan coast, Northwestern Mediterranean

8 pages, 6 figures, 1 table, supplementary material https://doi.org/10.1016/j.wasman.2023.05.021.-- Data availability: Data will be made available on requestThe seafloor of the Mediterranean Sea accumulates marine litter (ML), an area where bottom trawlers operate and can accidentally catch the litter from the seafloor. This study aims to describe and quantify the ML caught by bottom trawlers along the Catalan coast (NW Mediterranean Sea) and estimate the potential of the bottom trawl fleet to extract ML from the area as a Fishing for Litter (FFL) initiative to tackle the ML issue. Marine litter was collected from commercial trawlers and was classified as metal, plastic, rubber, textile, wood, and other waste and weighed (kg) from 305 hauls performed during three years (2019–2021) from 9 different ports at 3 different depths. ML was present in 97 % of the hauls, with plastic being the most abundant material. The composition varied according to zone, port and depth, with the highest densities found in highly urbanized areas (13.75 ± 3.25 kg km−2), which mainly contained plastics (74.3 %). The port of Barcelona had the highest presence of plastics (23.62 ± 6.49 kg km−2), mainly wet wipes. Regarding depth, the continental shelf had the highest density of ML, with 12.24 ± 2.40 kg km−2. The potential ML removal (t year−1) was calculated using fishing effort (hours). It is estimated that the bottom trawlers may potentially remove 237 ± 36 t year−1 of ML in the Catalan coast. FFL initiatives should be part of a multidisciplinary approach to tackle marine litter, which must include prevention, monitoring, and cleaning actionsThis work was supported by the Catalan Institute for Ocean Governance Research (ICATMAR), trawl surveys were financed by European Maritime and Fisheries Fund (EMFF) and the Catalan General Directorate of Marine Policy and Sustainable Fisheries by projects PESCAT (ARP029/18/00003) and CGCAT (ARP140/20/000006)With the institutional support of the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000928-S)Peer reviewe

Distribució Geogràfica de l’Esforç Pesquer i Captures de la Flota d’Encerclament Catalana (ICATMAR, 20-02)

23 pages, 15 figuresEn aquest informe es presenta la metodologia d’anàlisi i primers resultats de la distribució geogràfica de l’esforç i captures de la flota d’encerclament catalana a partir de dades VMS (Vessel Monitoring System) i ha estat realitzat per l’Institut Català de Recerca per a la Governança del Mar (ICATMAR), un òrgan de cooperació entre la Direcció General de Pesca i Afers Marítims del Departament d’Agricultura, Ramaderia, Pesca i Alimentació (DARP) de la Generalitat de Catalunya i l’Institut de Ciències del Mar (ICM) del Consejo Superior de Investigaciones Científicas (CSIC)Peer reviewe

Urine metabolome profiling of immune-mediated inflammatory diseases

Background: Immune-mediated inflammatory diseases (IMIDs) are a group of complex and prevalent diseases where disease diagnostic and activity monitoring is highly challenging. The determination of the metabolite profiles of biological samples is becoming a powerful approach to identify new biomarkers of clinical utility. In order to identify new metabolite biomarkers of diagnosis and disease activity, we have performed the first large-scale profiling of the urine metabolome of the six most prevalent IMIDs: rheumatoid arthritis, psoriatic arthritis, psoriasis, systemic lupus erythematosus, Crohn?s disease, and ulcerative colitis. Methods: Using nuclear magnetic resonance, we analyzed the urine metabolome in a discovery cohort of 1210 patients and 100 controls. Within each IMID, two patient subgroups were recruited representing extreme disease activity (very high vs. very low). Metabolite association analysis with disease diagnosis and disease activity was performed using multivariate linear regression in order to control for the effects of clinical, epidemiological, or technical variability. After multiple test correction, the most significant metabolite biomarkers were validated in an independent cohort of 1200 patients and 200 controls. Results: In the discovery cohort, we identified 28 significant associations between urine metabolite levels and disease diagnosis and three significant metabolite associations with disease activity (PFDR < 0.05). Using the validation cohort, we validated 26 of the diagnostic associations and all three metabolite associations with disease activity (PFDR < 0.05). Combining all diagnostic biomarkers using multivariate classifiers we obtained a good disease prediction accuracy in all IMIDs and particularly high in inflammatory bowel diseases. Several of the associated metabolites were found to be commonly altered in multiple IMIDs, some of which can be considered as hub biomarkers. The analysis of the metabolic reactions connecting the IMID-associated metabolites showed an overrepresentation of citric acid cycle, phenylalanine, and glycine-serine metabolism pathways. Conclusions: This study shows that urine is a source of biomarkers of clinical utility in IMIDs. We have found that IMIDs show similar metabolic changes, particularly between clinically similar diseases and we have found, for the first time, the presence of hub metabolites. These findings represent an important step in the development of more efficient and less invasive diagnostic and disease monitoring methods in IMIDs

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

Background: Patients with inflammatory bowel disease who achieve remission with anti-tumour necrosis factor (anti-TNF) drugs may have treatment withdrawn due to safety concerns and cost considerations, but there is a lack of prospective, controlled data investigating this strategy. The primary study aim is to compare the rates of clinical remission at 1?year in patients who discontinue anti-TNF treatment versus those who continue treatment. Methods: This is an ongoing, prospective, double-blind, multicentre, randomized, placebo-controlled study in patients with Crohn?s disease or ulcerative colitis who have achieved clinical remission for ?6?months with an anti-TNF treatment and an immunosuppressant. Patients are being randomized 1:1 to discontinue anti-TNF therapy or continue therapy. Randomization stratifies patients by the type of inflammatory bowel disease and drug (infliximab versus adalimumab) at study inclusion. The primary endpoint of the study is sustained clinical remission at 1?year. Other endpoints include endoscopic and radiological activity, patient-reported outcomes (quality of life, work productivity), safety and predictive factors for relapse. The required sample size is 194 patients. In addition to the main analysis (discontinuation versus continuation), subanalyses will include stratification by type of inflammatory bowel disease, phenotype and previous treatment. Biological samples will be obtained to identify factors predictive of relapse after treatment withdrawal. Results: Enrolment began in 2016, and the study is expected to end in 2020. Conclusions: This study will contribute prospective, controlled data on outcomes and predictors of relapse in patients with inflammatory bowel disease after withdrawal of anti-TNF agents following achievement of clinical remission. Clinical trial reference number: EudraCT 2015-001410-1

Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury

Ischemia-reperfusion injury (IRI) is a common event in organ transplantation. being implicated as a potential contributor for the development of chronic allograft nephropathy. There are new evidences showing a tissue inflammatory response following renal IRI Cyclooxygenases (COX) 1 and 2 can be detected in tissue submitted to IRI and may have impact on organ function outcome. We evaluated the role of COX inhibition on the renal tissue damage that follows M. Mice were submitted to 45 min of renal pedicle ligature and allowed to reperfuse for 24, 48, 72 and 120 h. Blood and kidney samples were collected at reperfusion times. mRNA was extracted from the kidney samples to amplify, COX-1: COX-2 and beta-actin genes. Animals were pretreated with indomethacin or rofecoxib before the surgery. Indomethacin treatment induced a better renal function (serum urea) when compared to control animals at 24, 48 and 72 h (219 +/- 54.5 vs. 338 +/- 51 mg/dl: 106 +/- 51 vs. 326 +/- 86 mg/dl; 94 +/- 14 vs. 138 +/- 38 mg/dl, respectively). Surprisingly, rofecoxib use was associated with even better renal improvement following IR. Animals treated with the later drug showed lower urea values at 24 h post reperfusion compared to indomethacin-treated animals (128 +/- 33 vs. 219 +/- 54.5 mg/dl, P < 0.05). Blockade of COX-1 and -2 resulted in a decrease of tubular necrosis. mRNA COX-2 was up-regulated post IRI and considerable inhibited after indomethacin or rofecoxib treatment. Our data show COX-1/-2 participates in the inflammatory tissue response to IR injury and its inhibition is associated with an improvement in renal function. (C) 2004 Elsevier B.V. All rights reserved.Universidade Federal de São Paulo, Clin & Expt Immunol Lab, Dept Med, Disciplina Nefrol,Hosp Rim & Hipertensao, BR-04023900 São Paulo, BrazilUniversidade Federal de São Paulo, Clin & Expt Immunol Lab, Dept Med, Disciplina Nefrol,Hosp Rim & Hipertensao, BR-04023900 São Paulo, BrazilWeb of Scienc

Estat de les Pesqueres a Catalunya 2019

310 pages, figures, tables, annexesEn aquest informe es presenta l’Estat de les Pesqueres a Catalunya entre novembre del 2018 i setembre del 2019 ambdós inclosos i ha estat realitzat per l’Institut Català de Recerca per a la Governança del Mar (ICATMAR), un òrgan de cooperació entre la Direcció General de Pesca i Afers Marítims del Departament d’Agricultura, Ramaderia, Pesca i Alimentació (DARP) de la Generalitat de Catalunya i l’Institut de Ciències del Mar (ICM) del Consejo Superior de Investigaciones Científicas (CSIC